Guru Ownership Trend
Guru Analysis for Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated (LGND), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $85.77 M.
Top institutional holders include Private Capital and Ken Fisher.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $13.94 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 40.4%. Conversely, Private Capital reduced exposure by 17.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Ligand Pharmaceuticals Incorporated (LGND)
Major holders include Private Capital ($52.48 M), Ken Fisher ($38.39 M), Cliff Asness ($3.3 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 301,510 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $13.94 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited LGND. The total reported sell value was $14.89 M.
Yes, 0 managers opened new positions in LGND, and 1 increased their existing holdings. The total reported buy value was $950,482.64.